Enhancing Information Security in Pharma

Information Security (IS) has become a core business risk rather than a purely technical concern for pharmaceutical and medtech companies as they accelerate digitalization of their core research, manufacturing, quality, and regulatory operations.

Proprietary formulation data, clinical and manufacturing records, and regulated electronic documentation all represent high-value targets for cyber threats, while regulatory expectations around data integrity, traceability, and controlled access continue to tighten. In this environment, robust IS becomes inseparable from regulatory compliance.

Twin challenges

For life sciences organisations operating under frameworks such as EU GMP Annex 11, FDA 21 CFR Part 11, GDPR, and, in some cases, HIPAA, the challenge is twofold: protecting sensitive data against unauthorized access or loss, while also demonstrating to regulators and partners that the organization’s digital systems are secure, validated, and under control throughout their lifecycle.

For practical purposes, the twin challenges are melded into one, since modern regulatory guidance increasingly treats data integrity and cybersecurity as interconnected disciplines. Compliance means fully secured and functional systems and vice versa.

Secure user access, audit trails, system validation, and controlled change management are no longer optional safeguards but fundamental requirements for compliant digital operations. Cyber incidents, data breaches, or poorly controlled systems can quickly translate into inspection findings, operational disruption, or reputational damage.

Holistic approaches

As a result, biopharmaceutical and medtech companies are seeking partners who can integrate IS into broader quality and compliance strategies — rather than addressing it as a standalone IT issue.

C-realize supports biopharmaceutical and medtech organisations in building secure, compliant digital ecosystems that align IS with regulatory expectations. Its services span the full lifecycle of computerized systems, from early risk assessment and system design through validation, deployment, and ongoing operation.

A core element of this approach is Computerized Systems Validation (CSV), ensuring that both new and legacy systems meet the requirements of EU GMP Annex 11 and FDA 21 CFR Part 11. By validating system functionality, access controls, electronic records, and audit trails, C-realize helps clients establish a strong technical and procedural foundation for information security.

Supporting structures

Beyond validation, C-realize supports governance and compliance structures that embed security into everyday operations. This includes risk-based assessments, documentation frameworks, SOP development, and training, ensuring that systems remain secure and compliant as regulations, technologies, and business needs evolve. Security and compliance audits, gap analyses, and ongoing monitoring services help identify vulnerabilities early and maintain a validated, inspection-ready state over time.

For organisations leveraging cloud or hybrid infrastructures, C-realize can also provide guidance and implementation support for secure, compliant hosting environments. These solutions are designed to balance scalability and performance with the stringent control and documentation requirements of regulated life sciences environments.

End-to-end assurance

One of the key benefits of working with C-realize is its end-to-end perspective. Rather than focusing on isolated technical controls, the company addresses IS across people, processes, and systems.

C-realize’s experience supporting clients in achieving internationally recognized standards such as ISO 27001 further underpins its ability to integrate IS management with quality systems. For biopharmaceutical and medtech companies, this translates into greater confidence — not only in day-to-day operations, but also during audits, inspections, and partner evaluations.

This approach fits the modern reality – that in an era of increasing cyber risk and regulatory scrutiny, IS can no longer be treated as an afterthought but must be designed into digital systems and structures from the outset and sustained throughout their lifecycle.

By combining deep regulatory knowledge with practical IS expertise, C-realize helps life sciences organisations protect their data, meet compliance obligations, and operate with confidence in a complex digital landscape.

Resources

Learn more about C-realize’s information security and compliance services.

C-realize provide help and support for all your Pharma, Biotech and Medical Devices needs in software development, cloud computing services and regulatory compliance advice and solutions, to learn more please book in an Introductory Consultation Session.